Ketryx, the agentic continuous compliance platform for safety-critical product development, announced today that William A. Hawkins, former Chairman and CEO of Medtronic, has joined its Board of Directors. Hawkins also participated in the company's Series B financing, signaling strong industry confidence in Ketryx's approach to solving the AI bottleneck in life sciences.
Hawkins brings decades of leadership experience in the medical device industry. As CEO of Medtronic from 2007 to 2011, he oversaw significant growth and innovation. His expertise will guide Ketryx as it expands its platform to help companies in safety-critical industries accelerate product development while maintaining compliance.
Ketryx's platform addresses a critical challenge: integrating AI into regulated workflows without compromising safety or compliance. The platform automatically generates compliant documentation, maintains continuous traceability, and enables safe and verifiable AI at scale within the tools teams already use. This reduces manual work by up to 90 percent and helps identify and close compliance gaps, improving both speed and quality across the product lifecycle.
Trusted by four of the world's top five medical device manufacturers, Ketryx transforms the product lifecycle of life sciences teams to deliver safer products, faster. The company's agentic continuous compliance platform overlays existing tools to automate documentation, create traceability, and accelerate release cycles without disrupting existing workflows.
For more information, visit www.ketryx.com.
